Mirum Pharmaceuticals Inc. said on Sept. 29 the company’s drug became the first U.S. approved therapy for treating itching in patients with a rare liver disorder called Alagille syndrome (ALGS).

German drugmaker Bayer will add a warning of rare cases of liver damage to the label of the prescription-free stomach relief drops Iberogast after Germany’s drugs regulator said a death was linked to the product.

Genotyping of patients with advanced cirrhosis from hepatitis C virus could help health-care professionals predict the likelihood of improvement after successful hepatitis C treatment, thus minimizing the need for liver transplants. This study was presented at Digestive Disease Week (DDW) 2017.